KLK4 has been identified as an indicator for breast, prostate, and ovarian cancer progression (Obiezu et al., 2001; Papachristopoulou et al., 2009; Lose et al., 2012; Wang et al., 2018). This evidence concerns the gene KLK4 and ovarian cancer.